Cite
Serological Response Following BNT162b2 Anti-Sars-Cov-2 mRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients
MLA
Attolico, Imma, et al. “Serological Response Following BNT162b2 Anti-Sars-Cov-2 MRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients.” Blood, vol. 138, no. 1, Number 1 Supplement 1, Nov. 2021, p. 4875. EBSCOhost, https://doi.org/10.1182/blood-2021-147542.
APA
Attolico, I., Tarantini, F., Carluccio, P., Schifone, C., Delia, M., Gagliardi, V. P., Perrone, T., Gaudio, F., Longo, C., Giordano, A., Sgherza, N., Curci, P., Rizzi, R., Ricco, A., Russo Rossi, A. V., Albano, F., Larocca, A. M. V., Vimercati, L., Tafuri, S., & Musto, P. (2021). Serological Response Following BNT162b2 Anti-Sars-Cov-2 mRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients. Blood, 138(1, Number 1 Supplement 1), 4875. https://doi.org/10.1182/blood-2021-147542
Chicago
Attolico, Imma, Francesco Tarantini, Paola Carluccio, Claudia Schifone, Mario Delia, Vito Pier Gagliardi, Tommasina Perrone, et al. 2021. “Serological Response Following BNT162b2 Anti-Sars-Cov-2 MRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients.” Blood 138 (1, Number 1 Supplement 1): 4875. doi:10.1182/blood-2021-147542.